Evidence map›Paper›PMID 42352514›Full record

ArticleCancers2026

The GAPP Aggressivity Score Correlates with Total Enriched Somatic Variant Burden in Sporadic Pheochromocytoma-A Pilot Study.

Reut Halperin, Gil Goldinger, Eddie Fridman, Naama Peshes Yaloz, Amit Tirosh, Gadi Shlomai

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Reut HalperinENTIRE-Endocrine Neoplasia Translational Research Center, The Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan 5266202, Israel.ORCID 0000-0002-8137-667X
Gil GoldingerGray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 6997801, Israel.
Eddie FridmanGray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 6997801, Israel.
Naama Peshes YalozENTIRE-Endocrine Neoplasia Translational Research Center, The Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan 5266202, Israel.
Amit TiroshENTIRE-Endocrine Neoplasia Translational Research Center, The Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan 5266202, Israel.
Gadi ShlomaiGray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 6997801, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPheochromocytomas and paragangliomas (PPGLs) can be metastatic in up to 30% of cases. To assess this risk, scoring systems like PASS and GAPP were developed, yet it is unclear whether these scores correlate with somatic genetic alterations.

methodsA retrospective pilot study. Twenty patients with sporadic pheochromocytoma, stratified into high- and low-risk groups based on GAPP and PASS scores. Somatic variant burden, derived from whole-exome sequencing, and clinical variables were compared between groups.

resultsSix patients (30.0%) comprised the high-risk group; all had PASS scores >4 and GAPP scores indicating moderately differentiated PPGLs. Compared with the low-risk group, the high-risk group had larger tumors (4.7 vs. 3.4 cm,

conclusionsHigher pathological severity scores are associated with increased rates of severe molecular somatic variants. The stronger link between GAPP score and genetic alteration rates suggests it may better reflect the genomic complexity of sporadic PPGLs.

Indexed as

GAPPPASSpheochromocytomarisk

Identifiers

PMID42352514
PMCPMC13296916

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.